Related Experiment Video
Updated: Oct 2, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
CRISPR in cancer biology and therapy
Alyna Katti1,2, Bianca J Diaz1,2, Christina M Caragine3,4
1Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Abstract:
Over the past decade, CRISPR has become as much a verb as it is an acronym, transforming biomedical research and providing entirely new approaches for dissecting all facets of cell biology. In cancer research, CRISPR and related tools have offered a window into previously intractable problems in our understanding of cancer genetics, the noncoding genome and tumour heterogeneity, and provided new insights into therapeutic vulnerabilities. Here, we review the progress made in the development of CRISPR systems as a tool to study cancer, and the emerging adaptation of these technologies to improve diagnosis and treatment.
More Related Videos
Related Concept Videos
CRISPR
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
Targeted Cancer Therapies
There are several types of targeted therapies against...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

